Praxis Precision Medicines (PRAX)
(Delayed Data from NSDQ)
$50.88 USD
+0.89 (1.78%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $50.89 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Brokerage Reports
Praxis Precision Medicines, Inc. [PRAX]
Reports for Purchase
Showing records 61 - 80 ( 104 total )
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
PRAX-114 Falls Flat in Aria, Company Returns Focus on Epilepsy and Movement Disorders
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Moving to Neutral, $4 Target - ARIA Miss Changes Thesis
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
PRAX-944 Shows More Than a Signal as Aria Waits in the Wings; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
More to PRAX Than Depression ? Epilepsy Day Provides Strategic Overview
Provider: Wedbush Securities Inc.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Delving Into the PRAX-114 Story - Management Call Takeaways
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
?114 Is Ready to Validate Best-in-Class Profile; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
The Final Countdown... ARIA Arrives in June, ACAPELLA to Follow
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Rx for Portfolios, Part 1: Companies With Transformative Clinical Readouts Fast Approaching
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Praxis Provides Update on Movement Disorder Franchise and Catalyst-Rich 2022 Ahead: 5 Key Takeaways
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
Moving Right Along - Movement Disorder Day Highlights
Provider: WEDBUSH SECURITIES INC.
Analyst: CHICO L
Company: Praxis Precision Medicines, Inc.
Industry: Medical - Biomedical and Genetics
PRAX-114 Poised to Fulfill Neurosteroid''s Potential in Depression; Initiate at Buy and $48 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D